Retinopathy Associated with Adjuvant High-Dose Interferon-α2b in a Patient with Resected Melanoma: A Case Report and Review of the Literature
Author:
Affiliation:
1. a NCIC Clinical Trials Group, Cancer Clinical Trials Division, Cancer Research Institute, Queen's University, Kingston, Ontario, Canada;
2. b Brockville General Hospital, Brockville, Ontario, Canada
Abstract
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
https://pericles-gcp.literatumonline.com/doi/pdf/10.1634/theoncologist.2011-0324
Reference21 articles.
1. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684;Kirkwood;J Clin Oncol,1996
2. Interferon alpha adjuvant therapy in patients with high-risk melanoma: A systematic review and meta-analysis;Mocellin;J Natl Cancer Inst,2010
3. Interferon-α as adjuvant therapy for melanoma: An individual patient data meta-analysis of randomised trials;Wheatley;J Clin Oncol,2007
4. Clinical toxicity of interferons in cancer patients: A review;Quesada;J Clin Oncol,1986
5. Randomized phase III trial of high-dose interferon alfa-2b (HDI) for 4 weeks induction only in patients with intermediate- and high-risk melanoma (Intergroup trial E 1697);Agarwala;J Clin Oncol,2011
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prospective study of clinical characteristics of melanoma patients with retinopathy caused by a high-dose interferon α-2b;Melanoma Research;2021-09-13
2. DNA Damage and p53 Restrict Proliferation of Müller Cells in the Mouse Retina in Response to the Influence of N-Methyl-N-Nitrosourea;Biophysics;2020-05
3. Ocular side effects of antirheumatic medications: a qualitative review;BMJ Open Ophthalmology;2020-01
4. Known and novel ocular toxicities of biologics, targeted agents, and traditional chemotherapeutics;Graefe's Archive for Clinical and Experimental Ophthalmology;2019-05-16
5. Ocular Paraneoplastic Diseases;Clinical Ophthalmic Oncology;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3